AI-Mind is a five-year EU-funded Horizon 2020 project on screening brain connectivity and dementia risk estimation in people affected by Mild Cognitive Impairment (MCI). AI-Mind is developing two AI-based tools that will identify dysfunctional brain networks and will assess dementia risk: the AIMind Connector and the AI-Mind Predictor. The AI-Mind Connector will fully automate the identification of early brain network disturbances; after enriching data from AI-Mind Connector with genetic and cognitive information, AI-Mind Predictor will provide an early marker of risk for dementia in people with MCI. Thus, the aim is to equip healthcare professionals with innovative tools that will enable timely diagnosis and extend the window for preventive interventions and therapies.
NORA has been supporting AI-Mind and the project coordinator, Dr. Ira Haraldsen, through the application phase. Through NORA, Dr. Haraldsen has connected with AI researchers at OsloMet and to international researchers through CLAIRE.
The AI-Mind application was successful, and 2021 was the kick off for this 14 million Euro project, the largest Horizon Europe R&I project within AI led from Norway.
The project’s consortium comprises medical experts and opinion leaders on dementia, experts on AI, brain signal anaysis, and computer science, SMEs and academic spin-off companies, patient and professional stakeholders and health technology assessment experts.
NORA now offer guidance and advice in the critical aspects of the AIMind project. We contribute as external support to all tasks related to AImodelling of the AI-Mind Connector and AI-Mind Predictor. NORA’s CEO Klas Pettersen is an active member of AI-Mind’s Scientific Advisory Board. Among others, Pettersen partici pated in person in the project’s General Assembly, which was held in Oslo in September 2021.